---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-262610"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:49:14.006752+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Daniel B. Soland resigns from Acadia board and governance committee chair

## Summary
- Resignation effective October 30, 2025.
- Mr. Soland stepped down from the Board and as Chair of Nominating and Corporate Governance Committee.
- Resignation not due to any dispute or disagreement with the Company or Board.
- No replacement for the Board seat or committee chair has been announced.

## SEC filing metadata
- accession: 0001193125-25-262610
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/0001193125-25-262610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/acad-20251028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-262610
- JSON: https://secwatch.observer/filing/0001193125-25-262610.json
- Plain text: https://secwatch.observer/filing/0001193125-25-262610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.